315 related articles for article (PubMed ID: 26580295)
1. The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.
Bidot S; Clough L; Saindane AM; Newman NJ; Biousse V; Bruce BB
J Neuroophthalmol; 2016 Jun; 36(2):120-5. PubMed ID: 26580295
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric papilledema in idiopathic intracranial hypertension.
Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
J Neuroophthalmol; 2015 Mar; 35(1):31-6. PubMed ID: 25494197
[TBL] [Abstract][Full Text] [Related]
3. Optic Nerve Angle in Idiopathic Intracranial Hypertension.
Chen BS; Asnafi S; Lin MY; Bruce BB; Lock JH; Sharma RA; Newman NJ; Biousse V; Saindane AM
J Neuroophthalmol; 2021 Dec; 41(4):e464-e469. PubMed ID: 34788243
[TBL] [Abstract][Full Text] [Related]
4. Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema.
Farrokhi Y; Sharif Kashani S; Aghsaei Fard M; Pakdel F; Yadegari S
Clin Neurol Neurosurg; 2019 Sep; 184():105376. PubMed ID: 31176474
[TBL] [Abstract][Full Text] [Related]
5. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
Gospe SM; Bhatti MT; El-Dairi MA
Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
[TBL] [Abstract][Full Text] [Related]
6. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension.
Heckmann JG; Faschingbauer F; Lang C; Reulbach U; Dütsch M; Mardin CY; Schwab S
J Neurosurg; 2007 Sep; 107(3):543-7. PubMed ID: 17886553
[TBL] [Abstract][Full Text] [Related]
7. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
8. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of translaminar, demographic, and physiologic parameters in relation to papilledema severity.
Fleischman D; Perry JT; Rand Allingham R; Stinnett SS; Fleischman GM; Givre SJ; Chesnutt DA
Can J Ophthalmol; 2017 Feb; 52(1):26-29. PubMed ID: 28237144
[TBL] [Abstract][Full Text] [Related]
10. Optic nerve diameters and perimetric thresholds in idiopathic intracranial hypertension.
Salgarello T; Tamburrelli C; Falsini B; Giudiceandrea A; Colotto A
Br J Ophthalmol; 1996 Jun; 80(6):509-14. PubMed ID: 8759260
[TBL] [Abstract][Full Text] [Related]
11. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
12. Retinal Manifestations of Idiopathic Intracranial Hypertension.
Nichani P; Micieli JA
Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.
Knoche T; Gaus V; Haffner P; Kowski A
Neurol Sci; 2023 Jun; 44(6):2131-2135. PubMed ID: 36689008
[TBL] [Abstract][Full Text] [Related]
14. Influence of Optic Nerve Appearance on Visual Outcome in Pediatric Idiopathic Intracranial Hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Newman NJ; Biousse V; Peragallo JH
Can J Neurol Sci; 2020 Sep; 47(5):661-665. PubMed ID: 32362301
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced 3D-FLAIR Imaging of the Optic Nerve and Optic Nerve Head: Novel Neuroimaging Findings of Idiopathic Intracranial Hypertension.
Golden E; Krivochenitser R; Mathews N; Longhurst C; Chen Y; Yu JJ; Kennedy TA
AJNR Am J Neuroradiol; 2019 Feb; 40(2):334-339. PubMed ID: 30679213
[TBL] [Abstract][Full Text] [Related]
16. Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach.
Vaidya NS; Mahmoud AM; Buzzacco D; Katz SE
Orbit; 2016 Oct; 35(5):271-7. PubMed ID: 27541942
[TBL] [Abstract][Full Text] [Related]
17. Correlation between papilledema grade and diffusion-weighted magnetic resonance imaging in idiopathic intracranial hypertension.
Salvay DM; Padhye LV; Huecker JB; Gordon MO; Viets R; Sharma A; Van Stavern GP
J Neuroophthalmol; 2014 Dec; 34(4):331-5. PubMed ID: 25000261
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Magnetic Resonance Imaging Characteristics of Postfenestration Optic Nerve Sheath Pseudomeningoceles.
Rafailov L; Rubinstein D; Wladis EJ; Mirani N; Frohman LP; Langer PD; Turbin RE
Ophthalmic Plast Reconstr Surg; 2019; 35(2):159-164. PubMed ID: 30134388
[TBL] [Abstract][Full Text] [Related]
19. Weight reduction for a better visual outcome in idiopathic intracranial hypertension.
Koc F; Isik MR; Sefi-Yurdakul N
Arq Bras Oftalmol; 2018; 81(1):18-23. PubMed ID: 29538589
[TBL] [Abstract][Full Text] [Related]
20. Papilledema: A review of etiology, pathophysiology, diagnosis, and management.
Xie JS; Donaldson L; Margolin E
Surv Ophthalmol; 2022; 67(4):1135-1159. PubMed ID: 34813854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
